Literature DB >> 9358473

Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity.

J Uitto1, L Pulkkinen, W H McLean.   

Abstract

Great progress has recently been made in understanding the molecular basis of various heritable skin diseases. A prototype of such conditions is epidermolysis bullosa (EB), a heterogeneous group of mechano-bullous disorders characterized by fragility of the skin and other specialized epithelia. Blistering of the skin in EB results either from fragility of epidermal cells or from defective attachment of the epidermis to the underlying dermis, because of genetic lesions within molecules of the basement-membrane zone at the dermal-epidermal junction. Distinct mutations have been discovered in ten different genes encoding the structural components within this layer. The combinations and the types of mutations, as well as their positions in the altered gene products, collectively reflect the phenotypic variability observed in this group of heritable skin diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358473     DOI: 10.1016/s1357-4310(97)01112-x

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  14 in total

1.  A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

Authors:  Jason A Bubier; Thomas J Sproule; Lydia M Alley; Cameron M Webb; Jo-David Fine; Derry C Roopenian; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-03-25       Impact factor: 8.551

2.  Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions.

Authors:  Jie Li; Lisa Zhou; Hoang T Tran; Yi Chen; Ngon E Nguyen; Marvin A Karasek; M Peter Marinkovich
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

3.  Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors:  L Pulkkinen; D U Kim; J Uitto
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 4.  From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Authors:  Beau R Webber; Jakub Tolar
Journal:  Mol Ther       Date:  2015-03-24       Impact factor: 11.454

5.  Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer.

Authors:  J Hao; L Jackson; R Calaluce; K McDaniel; B L Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 6.  The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.

Authors:  Isis C Sroka; Todd A Anderson; Kathy M McDaniel; Raymond B Nagle; Matthew B Gretzer; Anne E Cress
Journal:  J Cell Physiol       Date:  2010-08       Impact factor: 6.384

7.  Expression of Laminin γ2 Proteolytic Fragments in Murine Skin Following Exposure to Sulfur Mustard.

Authors:  Yoke-Chen Chang; James D Wang; Hui-Ying Chang; Peihong Zhou; Rita A Hahn; Marion K Gordon; Jeffrey D Laskin; Donald R Gerecke
Journal:  Anat Rec (Hoboken)       Date:  2020-05-18       Impact factor: 2.064

Review 8.  The expanding significance of keratin intermediate filaments in normal and diseased epithelia.

Authors:  Xiaoou Pan; Ryan P Hobbs; Pierre A Coulombe
Journal:  Curr Opin Cell Biol       Date:  2012-12-25       Impact factor: 8.382

9.  In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.

Authors:  P B Robbins; Q Lin; J B Goodnough; H Tian; X Chen; P A Khavari
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

10.  Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.

Authors:  L Pulkkinen; F Rouan; L Bruckner-Tuderman; R Wallerstein; M Garzon; T Brown; L Smith; W Carter; J Uitto
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.